from Reuters: Health News https://ift.tt/2W5ex1M
via IFTTT
Tuesday, May 5, 2020
Australia's CSL to start work on immunoglobulin product to treat COVID-19
Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.
from Reuters: Health News https://ift.tt/2W5ex1M
via IFTTT
from Reuters: Health News https://ift.tt/2W5ex1M
via IFTTT
0 comments:
Post a Comment